Reading a certificate of analysis (COA)

A certificate of analysis, commonly abbreviated as COA, is the analytical document that accompanies a batch of research peptide and reports the results of the quality control testing performed on that batch. For a research laboratory sourcing material from originlabsresearch.com or any other supplier, the COA is the primary objective evidence that the substance in the vial corresponds to the substance on the label and that its purity is within the stated specification. Reading a COA is a learned skill, and the ability to interpret the data has been referenced in laboratory quality assurance literature as a baseline competency for researchers handling chemically synthesised compounds. The fields that typically appear on a peptide COA include the identity of the compound, the lot or batch number, the date of analysis, the analytical methods used, the results of each test, the specification limits for the test, and a pass-or-fail determination. The methods most commonly referenced for peptide COAs are reverse-phase high-performance liquid chromatography for purity, mass spectrometry for identity confirmation, Karl Fischer titration for residual moisture, and limulus amoebocyte lysate assay for endotoxin where applicable. This guide explains each field on a typical peptide COA, describes how to interpret the data, and outlines the signs that distinguish a credible COA from a low-quality or fabricated one. The material is supplied for research purposes only.

HPLC purity and what the chromatogram shows

Reverse-phase high-performance liquid chromatography is the most widely referenced analytical method for determining the purity of a synthesised peptide. The principle is that a sample of the peptide is dissolved in a polar mobile phase, injected onto a hydrophobic stationary phase column, and gradually eluted by increasing the proportion of organic solvent in the mobile phase. Different chemical species in the sample elute at different times based on their hydrophobicity, and a detector at the column outlet records the absorbance at a chosen wavelength, typically 214 or 220 nanometres for peptide bond absorbance. The resulting chromatogram shows peaks corresponding to each species in the sample. The main peak corresponds to the target peptide, and the surrounding smaller peaks correspond to impurities, which may include truncated sequences, deletion sequences, oxidation products, or residual solvents. Purity is calculated as the area of the main peak divided by the total area of all integrated peaks, expressed as a percentage. A COA should report this percentage as the HPLC purity, and a well-prepared COA will include the actual chromatogram image or a reference to a separate attached file. Research-grade peptide COAs typically report HPLC purity values of 98 percent or higher for catalog peptides. Values below 95 percent are unusual and should prompt closer examination of the impurity profile. A flat or unrealistically clean chromatogram with no detectable impurity peaks at all is itself a sign that the chromatogram may have been fabricated, since real synthesis batches always carry some impurity signature.

Mass spectrometry and identity confirmation

Mass spectrometry is the analytical method most commonly used to confirm the identity of a peptide. The principle is that the peptide is ionised and the mass-to-charge ratio of the resulting ions is measured. The observed mass is compared to the theoretical mass calculated from the amino acid sequence, and a match within the accuracy of the instrument confirms that the sample corresponds to the expected peptide. The most commonly referenced techniques are electrospray ionisation mass spectrometry and matrix-assisted laser desorption ionisation. A well-prepared peptide COA will report both the theoretical molecular weight and the observed mass, and the two should match within the resolution of the instrument, typically to within one mass unit for peptides under 5,000 Daltons. The COA may also include the mass spectrum image showing the observed ion peaks. Mass spectrometry confirms the identity of the major species in the sample but does not by itself confirm purity, which is why HPLC and mass spectrometry are reported together. A peptide that passes mass spectrometry identity confirmation but fails HPLC purity could correspond to a correct peptide present alongside significant impurities. A peptide that passes HPLC purity but fails mass spectrometry identity could correspond to a chemically pure substance that is not the intended peptide. Both tests are necessary for a complete quality determination, and a credible COA reports both.

Batch numbering, traceability, and audit trail

Batch numbering on a COA provides the traceability link between the analytical results reported on the document and the physical material in the vial. A batch or lot number is assigned by the manufacturer at the moment a particular synthesis is completed, and that number is recorded on the COA, on the vial label, and in the manufacturer's internal records. The relationship is one COA per batch, and one batch may correspond to many vials packaged from the same synthesis run. A credible COA will include the batch number prominently, along with the date of synthesis, the date of analysis, and the name of the analyst or the laboratory that performed the testing. The batch number on the vial label received by the researcher must match the batch number on the COA, and if it does not, the supplier should be contacted before the material is used. Traceability is the principle that links every result in the laboratory back to the original material, and a missing or mismatched batch number breaks that chain. A high-quality COA may also include the names of the analysts, the instrument identifiers, and the calibration status of the equipment used. These elements are common in pharmaceutical-grade COAs but less common in research-grade COAs. A COA with no batch number, no analyst signature, no date, or no specific reference to the testing instrument is a low-quality COA and should be treated with caution.

Residual solvents, moisture, and endotoxin

Beyond purity and identity, several additional tests are commonly referenced on a peptide COA. Residual solvent analysis quantifies the amount of organic solvent remaining in the lyophilised peptide from the synthesis and purification process. Common residual solvents include acetonitrile, trifluoroacetic acid, dichloromethane, and dimethylformamide. Limits for residual solvents are referenced in pharmacopeial guidelines and are typically reported in parts per million on a research-grade COA. Moisture content is measured by Karl Fischer titration and is reported as a percentage of the total mass of the lyophilised cake. Moisture in the range of 1 to 5 percent is typical for well-prepared lyophilised peptide. High moisture values can indicate incomplete drying or compromised storage. Endotoxin testing is performed by limulus amoebocyte lysate assay and quantifies bacterial lipopolysaccharide contamination. Endotoxin testing is not always present on research-grade COAs, since the material is not intended for human or animal use. When endotoxin results are reported, they are expressed as endotoxin units per milligram of peptide. Counterion content, particularly trifluoroacetate from cleavage and purification steps, is sometimes reported and can affect the actual mass of pure peptide in a vial that lists a nominal mass. Researchers comparing two vials of nominally identical peptide should review counterion content if available, since different counterion loadings can change the effective peptide content by several percent.

How to spot a low-quality or fabricated COA

Several characteristics have been associated with low-quality or fabricated certificates of analysis in peptide handling literature. The first is the absence of an actual chromatogram or mass spectrum image, with only a numerical result reported. A credible COA will either include the chromatogram and mass spectrum or will reference a separately attached file. The second is the reporting of implausibly clean results, such as 99.99 percent HPLC purity with no detectable impurity peaks at all. Real synthesis batches always carry a measurable impurity signature, and an unrealistically clean result is a marker of fabrication. The third is the absence of batch traceability information, including no batch number, no synthesis date, no analyst identification, and no instrument reference. The fourth is the use of generic template language that could apply to any peptide, with no specific data points unique to the batch in question. The fifth is the appearance of identical COA images for multiple distinct batches, which can be detected by comparing chromatogram baseline noise patterns and the position of minor impurity peaks. The sixth is the absence of any specification limits, with only the result reported and no statement of what the result is being measured against. A credible COA reports both the result and the specification, and provides a clear pass-or-fail determination. The seventh is a COA that has been altered or photoshopped, with mismatched fonts, inconsistent date formats, or visible image artefacts. Researchers who have any concern about the authenticity of a COA should request the original analytical files directly from the supplier and should consider requesting third-party verification of the batch.

References

1. [1] Eggen I, Gregg B, Rode H, Swietlow A, Verlander M, Szajek A (2014). Control strategies for synthetic therapeutic peptide APIs Part III: Manufacturing process considerations. Pharmaceutical Technology.
2. [2] Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS (2007). HPLC analysis and purification of peptides. Methods in Molecular Biology. PMID 17554798
3. [3] Lobas AA, Verenchikov AN, Goloborodko AA, Levitsky LI, Gorshkov MV (2013). Top-down protein characterization by mass spectrometry. Mass Spectrometry Reviews.
4. [4] Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B (2009). Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. Journal of Peptide Science. PMID 19536898

Frequently asked questions